About

We are economists and thinkers from a range of disciplines who challenge conventional wisdom and advance ideas to better serve society.

Research

We develop research that challenges economic orthodoxy and serves society.

Articles

Commentary, analysis, interviews, and research summaries by INET-affiliated writers.

Video

Interviews, presentations and video series with provocative economic thinkers, public figures and students.

Podcast

Economics and Beyond with Rob Johnson, a podcast featuring interviews with some of the world’s most important thinkers, artists, and activists about the pressing issues of our time. The podcast is also available on all major podcasting platforms, such as Apple, Spotify, Google, and Podbean.

Education

Video series and courses for students and educators interested in exploring new economic thinking.

Events

To foster new economic thinking, we host convenings that gather together a diverse community of thinkers from different fields, countries, and schools of thought.

YSI

Through the Young Scholars Initiative (YSI), INET provides support to students, young professionals, or others who embrace new and critical ways of thinking about the economy. YSI fosters conversation among those who wish to engage with new economic thinking and connects young scholars to the Institute’s vast network of economists.

Topics

Browse all INET content organized by topic

Archive

Working Paper
Working Paper Series
Measuring the Impact of Campaign Finance on Congressional Voting: A Machine Learning Approach

By Matthias Lalisse

Mar 2022

Using aggregate campaign finance data as well as a Transformer based text embedding model we can predict roll call votes for legislation in the US Congress with more than 90% accuracy.
Working Paper
Working Paper Series
Predicting United States Policy Outcomes with Random Forests

By Shawn K. McGuire and Charles B. Delahunt

Nov 2020

In this paper we analyze the Gilens dataset using the complementary tools of Random Forest classifiers (RFs), from Machine Learning.
Working Paper
Working Paper Series
Government as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019

By Ekaterina Cleary, Matthew Jackson, and Fred Ledley

Sep 2020

Amid debates over costs—and profits—from a coronavirus vaccine, a new study shows that taxpayers have been footing the bill for every new drug approved between 2010 and 2019
Working Paper
Working Paper
How “Maximizing Shareholder Value” Minimized the Strategic National Stockpile: The $5.3 Trillion Question for Pandemic Preparedness Raised by the Ventilator Fiasco

By William Lazonick and Matt Hopkins

Jul 2020

The success of projects for pandemic preparedness and response depends on the strength of government-business collaborations.